Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Occupational therapy for persons with cognitive impairments.
Schnell-Inderst P, Conrads-Frank A, Stojkov I, Krenn C, Kofler LM, Siebert U. Schnell-Inderst P, et al. Among authors: stojkov i. Ger Med Sci. 2023 Apr 4;21:Doc02. doi: 10.3205/000316. eCollection 2023. Ger Med Sci. 2023. PMID: 37260919 Free PMC article. Review.
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.
Stojkov I, Conrads-Frank A, Rochau U, Arvandi M, Koinig KA, Schomaker M, Mittelman M, Fenaux P, Bowen D, Sanz GF, Malcovati L, Langemeijer S, Germing U, Madry K, Guerci-Bresler A, Culligan DJ, Kotsianidis I, Sanhes L, Mills J, Puntscher S, Schmid D, van Marrewijk C, Smith A, Efficace F, de Witte T, Stauder R, Siebert U. Stojkov I, et al. Blood Adv. 2023 Jun 27;7(12):2772-2783. doi: 10.1182/bloodadvances.2022008360. Blood Adv. 2023. PMID: 36607832 Free PMC article. Clinical Trial.
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project.
Efficace F, Koinig K, Cottone F, Bowen D, Mittelman M, Sommer K, Langemeijer S, Culligan D, Filanovsky K, Storck M, Smith A, van Marrewijk C, Dugas M, Stojkov I, Siebert U, de Witte T, Stauder R. Efficace F, et al. Among authors: stojkov i. Cancer Med. 2023 Mar;12(6):7529-7539. doi: 10.1002/cam4.5487. Epub 2022 Dec 19. Cancer Med. 2023. PMID: 36533415 Free PMC article.
Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness.
Kuehne F, Arvandi M, Hess LM, Faries DE, Matteucci Gothe R, Gothe H, Beyrer J, Zeimet AG, Stojkov I, Mühlberger N, Oberaigner W, Marth C, Siebert U. Kuehne F, et al. Among authors: stojkov i. J Clin Epidemiol. 2022 Dec;152:269-280. doi: 10.1016/j.jclinepi.2022.10.005. Epub 2022 Oct 15. J Clin Epidemiol. 2022. PMID: 36252741 Free article. Clinical Trial.
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.
Stojkov I, Conrads-Frank A, Rochau U, Koinig KA, Arvandi M, Puntscher S, van Marrewijk C, Fenaux P, Symeonidis A, Chermat F, Garelius H, Bowen D, Mittelman M, Mora E, de Witte T, Efficace F, Siebert U, Stauder R. Stojkov I, et al. Blood Adv. 2022 Jan 11;6(1):1-12. doi: 10.1182/bloodadvances.2021004568. Blood Adv. 2022. PMID: 34492684 Free PMC article.
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.
Jahn B, Sroczynski G, Bicher M, Rippinger C, Mühlberger N, Santamaria J, Urach C, Schomaker M, Stojkov I, Schmid D, Weiss G, Wiedermann U, Redlberger-Fritz M, Druml C, Kretzschmar M, Paulke-Korinek M, Ostermann H, Czasch C, Endel G, Bock W, Popper N, Siebert U. Jahn B, et al. Among authors: stojkov i. Vaccines (Basel). 2021 Apr 27;9(5):434. doi: 10.3390/vaccines9050434. Vaccines (Basel). 2021. PMID: 33925650 Free PMC article.
14 results